Selegiline Hydrochloride
- Product NDC
- 10135-737
- 11-digit product format
- 101350737
- Labeler code
- 10135
- Product ID
- 10135-737_441eef3c-3c0d-08b3-e063-6394a90afef9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Selegiline Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals, Inc.
- Application
- ANDA075352
- Marketing category
- ANDA
- Marketing start
- 2021-05-01
- Substance
- SELEGILINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Selegiline Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SELEGILINE HYDROCHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6W731X367Q |
| Rxcui | 859186 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-737-60 | Selegiline Hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-737 | SELEGILINE HYDROCHLORIDE CAPSULE [MARLEX PHARMACEUTICALS, INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20241019_df88d6bf-0fda-3825-e053-2a95a90a3a75.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10135-737-60 | 10135073760 | 60 CAPSULE in 1 BOTTLE (10135-737-60) | 60 capsule | 2021-05-01 | 0000-00-00 | No | No | Current |